{"AllianceGenome": "6373", "HGNC": "6373", "MIM": "602890", "_id": "3820", "_version": 1, "accession": {"genomic": ["AC006432.15", "CH471094.1", "CP068266.2", "NC_000012.12", "NC_060936.1"], "protein": ["AAA21605.1", "AAI13998.1", "AAI14517.1", "BAF84711.1", "EAW96108.1", "NP_002249.1", "Q12918.1"], "rna": ["AK292022.1", "BC027885.1", "BC113997.1", "BC114516.1", "BF432813.1", "NM_002258.3", "U11276.1"], "translation": [{"protein": "AAI14517.1", "rna": "BC114516.1"}, {"protein": "BAF84711.1", "rna": "AK292022.1"}, {"protein": "AAA21605.1", "rna": "U11276.1"}, {"protein": "NP_002249.1", "rna": "NM_002258.3"}, {"protein": "AAI13998.1", "rna": "BC113997.1"}]}, "alias": ["CD161", "CLEC5B", "NKR", "NKR-P1", "NKR-P1A", "NKRP1A", "hNKR-P1A"], "ensembl": {"gene": "ENSG00000111796", "protein": "ENSP00000229402", "transcript": "ENST00000229402", "translation": [{"protein": "ENSP00000229402", "rna": "ENST00000229402"}], "type_of_gene": "protein_coding"}, "entrezgene": "3820", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 10.4974271943, "exp_mis": 60.0877233756, "exp_syn": 24.5381823292, "lof_z": 0.457819173297232, "mis_z": -0.499258317947158, "mu_lof": 7.36323431116e-07, "mu_mis": 5.31068972359e-06, "mu_syn": 2.03450716758e-06, "n_lof": 9.0, "n_mis": 68.0, "n_syn": 25.0, "p_li": 4.43124831904582e-06, "p_null": 0.607502016917662, "p_rec": 0.392493551834019, "syn_z": -0.0577964316441107}, "bp": 678, "cds_end": 9760435, "cds_start": 9747869, "n_exons": 6, "nonpsych": {"exp_lof": 9.38161732907, "exp_mis": 54.2656222689, "exp_syn": 22.0898568249, "lof_z": 0.122360487668755, "mis_z": -0.461101892001164, "mu_lof": 7.36323431116e-07, "mu_mis": 5.31068972359e-06, "mu_syn": 2.03450716758e-06, "n_lof": 9.0, "n_mis": 61.0, "n_syn": 24.0, "p_li": 2.22534164978322e-06, "p_null": 0.738775441073529, "p_rec": 0.261222333584821, "syn_z": -0.255877581153997}, "nontcga": {"exp_lof": 9.64597869829, "exp_mis": 55.2690547207, "exp_syn": 22.5634752406, "lof_z": 0.205175884350327, "mis_z": -0.518085448605027, "mu_lof": 7.36323431116e-07, "mu_mis": 5.31068972359e-06, "mu_syn": 2.03450716758e-06, "n_lof": 9.0, "n_mis": 63.0, "n_syn": 20.0, "p_li": 2.59054874462193e-06, "p_null": 0.697100227026467, "p_rec": 0.302897182424789, "syn_z": 0.341703341943073}, "transcript": "ENST00000229402.3"}, "exons": [{"cdsend": 9607839, "cdsstart": 9595273, "chr": "12", "position": [[9594550, 9595421], [9598045, 9598161], [9598498, 9598653], [9599766, 9599841], [9601500, 9601599], [9607754, 9607916]], "strand": -1, "transcript": "NM_002258", "txend": 9607916, "txstart": 9594550}], "exons_hg19": [{"cdsend": 9760435, "cdsstart": 9747869, "chr": "12", "position": [[9747146, 9748017], [9750641, 9750757], [9751094, 9751249], [9752362, 9752437], [9754096, 9754195], [9760350, 9760512]], "strand": -1, "transcript": "NM_002258", "txend": 9760512, "txstart": 9747146}], "generif": [{"pubmed": 16339512, "text": "Engagement of CD161 on NK cells with LLT1 expressed on target cells inhibited NK cell-mediated cytotoxicity and IFN-gamma secretion. LLT1/CD161 interaction in the presence of a TCR signal enhanced IFN-gamma production by T cells"}, {"pubmed": 16339513, "text": "LLT1 on target cells can inhibit NK cytotoxicity via interactions with CD161. LLT1 activates NFAT-GFP reporter cells expressing a CD3zeta-CD161 chimeric receptor; reciprocally, reporter cells with a CD3zeta-LLT1 chimeric receptor are stimulated by CD161"}, {"pubmed": 16455998, "text": "define a novel signal transduction pathway for the CD161 (NKR-P1A) receptor and provide fresh insights into NK and NKT cell biology"}, {"pubmed": 16925668, "text": "NKRPIA binds to the alphaGal epitope of mouse laminin. Moreover, exposing NAcLac by removal of alphaGal resulted in an increase in binding."}, {"pubmed": 18159636, "text": "The results of this work demonstrated that the transcription of the KLRB1 was suppressed in tumor tissues in 68% patients with nonsmall-lung-cancer (p < 0.0001) and 57% patients with esophageal squamous-cell carcinoma (p = 0.0003)."}, {"pubmed": 18219672, "text": "Expression of CD161 indicates a unique pattern of T cell differentiation that might help elucidate the mechanisms of hepatitis c virus immunity and pathogenesis."}, {"pubmed": 18453569, "text": "Interactions between NKR-P1A on NK cells and LLT1 on target cells inhibit NK cell-mediated cytotoxicity and cytokine production"}, {"pubmed": 18550855, "text": "PILAR signaling through CD161 supports CD3 antibody-dependent and antigen-specific T-cell proliferation by increasing the expression of antiapoptotic Bcl-xL and induces secretion of T helper type 1 cytokines"}, {"pubmed": 18663128, "text": "all IL-17-producing cells originate from CD161(+) naive CD4(+) T cells of umbilical cord blood, as well as of the postnatal thymus"}, {"pubmed": 19273624, "text": "These data identify CD161(+) CD4 T cells as a resting Th17 pool that can be activated by IL-23 and mediate destructive tissue inflammation."}, {"pubmed": 19506219, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19711124, "text": "There is a significant positive correlation of CD161 expression with NK cytotoxicity."}, {"pubmed": 19834503, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20133607, "text": "CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties."}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20359956, "text": "Results reveal a functional relationship between CD161 expression and NK cell cytotoxicity as well as NK cell reactivity to glycans and mutated citrullinated vimentin, providing new insight into the pathogenesis of rheumatoid arthritis."}, {"pubmed": 20486123, "text": "marker of IL-17-producing T-cell subsets"}, {"pubmed": 20800424, "text": "cytokines induce significant up-regulation of NKG2D expression while only IFN-alpha induced significant up-regulation of CD161"}, {"pubmed": 21570678, "text": "Th17 cells from patients with head and neck squamous cell carcinoma downregulate the Th17 cell surface receptor CD161 in peripheral blood as well as in primary tumors and especially in metastatic lymph nodes."}, {"pubmed": 21572041, "text": "Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1)."}, {"pubmed": 21610746, "text": "our results indicate that KLRB1 gene expression is altered in multiple sclerosis (MS) and likely to be involved in the pathogenesis of the disease, whereas rs4763655 in KLRB1 seems to have a minimal role in MS susceptibility."}, {"pubmed": 21909091, "text": "expression defines IL-25- and IL-33-responsive type 2 innate lymphoid cells"}, {"pubmed": 21930700, "text": "LLT1 and CD161 have roles in modulating immune responses to pathogens; and interferon-gamma contributes to modulate immune responses"}, {"pubmed": 22833233, "text": "CD161+CD4+ T lymphocytes, differentiated into Th1 cells and Th17 cells, are involved in the pathogenesis of giant cell arteritis and polymyalgia rheumatica."}, {"pubmed": 23355538, "text": "Here we present a distinct population of Treg, defined by CD161 expression, as the major source of FoxP3+ Treg-derived proinflammatory cytokines."}, {"pubmed": 23599932, "text": "The fraction of CD161high T cells is significantly higher in cerebrospinal fluid of patients with multiple sclerosis in relapse than those of controls."}, {"pubmed": 24392804, "text": "CD161+ Th17/CD161+ Th1-cell imbalance may contribute to the development of rheumatoid arthritis."}, {"pubmed": 24975965, "text": "Elevated expression of CD69 and CD161 on NK cells can be considered as immunological risk markers in RSA and IVF failure."}, {"pubmed": 25172498, "text": "CD39 and CD161 modulate human Th17 responses in CD through alterations in purinergic nucleotide-mediated responses and ASM catalytic bioactivity, respectively."}, {"pubmed": 25437561, "text": "Expression of CD161 hence identifies a transcriptional and functional phenotype, shared across human T lymphocytes."}, {"pubmed": 25543092, "text": "these results suggest that the CD8(+) subset of CD161(+) T cells may have regulatory effects and that they provide a basis for predicting the occurrence of aGVHD after allogeneic SCT."}, {"pubmed": 25906076, "text": "percentage of alveolar CD3(+)CD161(+) T lymphocytes that produced IFN-gamma/IL-17 was significantly higher than those in the peripheral blood"}, {"pubmed": 26059452, "text": "We suggest modulation of human Th17 responsiveness by CD39 and CD161 and describe novel molecular mechanisms integrating elements of both extracellular nucleotide and sphingolipid homeostasis--{REVIEW}"}, {"pubmed": 26062995, "text": "CD161-expressing Th17 cells are enriched at sites of autoinflammation, are highly proinflammatory and resistant to Treg-mediated suppression suggesting their important pathogenic role in rheumatoid arthritis."}, {"pubmed": 26220166, "text": "A novel population of highly functional, memory CD8+ T cells enriched within the gut expresses CD161."}, {"pubmed": 26309225, "text": "The regulation of NK cell homeostasis and activation apparently differs between carriers of the CC and TT variant of CD161."}, {"pubmed": 26590595, "text": "CD161 expression levels were reduced in some NK and T cell subpopulations of systemic lupus erythematosus (SLE) patients, suggesting possible important role of CD161 and CD161-expressing immune cells in the SLE pathogenesis."}, {"pubmed": 26643453, "text": "Our results reveal that in combination with IGRAs, CD161-based indices provide a novel, fast diagnostic solution addressing the limitation of current tuberculosis diagnostics."}, {"pubmed": 26829983, "text": "these data suggest that LLT1-CD161 interactions play a novel and important role in B cell maturation within the Germinal center in humans."}, {"pubmed": 27626681, "text": "Blocking LLT1-NKRP1A interaction will make prostate cancer cells susceptible to killing by NK cells, suggesting a therapeutic option for treatment of prostate cancer."}, {"pubmed": 27821506, "text": "A subset of virus-specific CD161(+) T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in acute myeloid leukemia."}, {"pubmed": 28757467, "text": "Purified soluble NKR-P1 is homogeneous, deglycosylatable, crystallizable and monomeric in solution, as shown by size-exclusion chromatography, multi-angle light scattering and analytical ultracentrifugation."}, {"pubmed": 29111570, "text": "The killer cell lectin-like receptor B1 (KLRB1) 503T>C polymorphism (rs1135816) and acute rejection after liver transplantation."}, {"pubmed": 29212911, "text": "These results show that susceptibility of normal articular chondrocytes to lysis by NK cells is modulated by NKR-P1A/LLT1 interactions. Thus, NKR-P1A/LLT1 interaction might provide some novel target for therapeutic interventions in the course of pathological cartilage injury."}, {"pubmed": 29686665, "text": "CD161 expression identifies NK cells that may contribute to inflammatory disease pathogenesis and correlates with an innate responsiveness to cytokines in both T and NK cells."}, {"pubmed": 31002602, "text": "REVIEW: Biological and Clinical Significance of Human NKRP1A/LLT1 Receptor/Ligand Interactions"}, {"pubmed": 31017304, "text": "this study shows that chronic inflammation during osteoarthritis is associated with an increased expression of CD161 during advanced stage"}, {"pubmed": 31145102, "text": "CD161 has a role in prenatal immune suppression of IFNgamma-producing PLZF+ T cells"}, {"pubmed": 31305900, "text": "These novel results suggest that CD161 is often aberrantly expressed in a defined subset of T-cell prolymphocytic leukemia positive for CD8."}, {"pubmed": 32159362, "text": "Extracellular ATP, P2Rs, ecto-nucleotidases, adenosine, and P1Rs are basic elements of the purinergic signaling network and fundamental pillars of inflammation."}, {"pubmed": 32416673, "text": "Transcription/Expression of KLRB1 Gene as A Prognostic Indicator in Human Esophageal Squamous Cell Carcinoma."}, {"pubmed": 33368526, "text": "C-type lectin-like CD161 is not a co-signalling receptor in gluten-reactive CD4 + T cells."}, {"pubmed": 33592174, "text": "Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis."}, {"pubmed": 34305920, "text": "A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint."}, {"pubmed": 34881489, "text": "Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples."}, {"pubmed": 35185935, "text": "LLT1-CD161 Interaction in Cancer: Promises and Challenges."}, {"pubmed": 35611672, "text": "Immunobiology and conflicting roles of the human CD161 receptor in T cells."}, {"pubmed": 36633583, "text": "CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer."}, {"pubmed": 37287972, "text": "SARS-CoV-2 infection impairs NK cell functions via activation of the LLT1-CD161 axis."}, {"pubmed": 37551093, "text": "Eosinophilic allergic rhinitis is strongly associated with the CD45RB[lo] subset of CD161[+] Th2 cells that secretes IL-2, IL-3, IL-4, IL-5, IL-9, and IL-13."}, {"pubmed": 37988189, "text": "Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients."}, {"pubmed": 38502058, "text": "Immune checkpoint CD161/LLT1-associated immunological landscape and diagnostic value in oral squamous cell carcinoma."}, {"pubmed": 38608099, "text": "A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review."}, {"pubmed": 38636371, "text": "KLRB1 defines an activated phenotype of CD4+ T cells and shows significant upregulation in patients with primary Sjogren's syndrome."}, {"pubmed": 38782996, "text": "Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD."}, {"pubmed": 38914941, "text": "Deciphering the role of KLRB1: a novel prognostic indicator in hepatocellular carcinoma."}], "genomic_pos": {"chr": "12", "end": 9607916, "ensemblgene": "ENSG00000111796", "start": 9594551, "strand": -1}, "genomic_pos_hg19": {"chr": "12", "end": 9760482, "start": 9747147, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0007166", "pubmed": 8077657, "qualifier": "involved_in", "term": "cell surface receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0042269", "qualifier": "involved_in", "term": "regulation of natural killer cell mediated cytotoxicity"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0009986", "qualifier": "is_active_in", "term": "cell surface"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0004888", "pubmed": 8077657, "qualifier": "enables", "term": "transmembrane signaling receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 21572041, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0030246", "qualifier": "enables", "term": "carbohydrate binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0038023", "qualifier": "enables", "term": "signaling receptor activity"}]}, "homologene": {"genes": [[9544, 100430783], [9598, 736832], [9606, 3820], [9615, 100684789], [9913, 407181], [9913, 100138381], [10090, 17057], [10090, 17059], [10090, 80782], [10116, 25192], [10116, 362443]], "id": 84369}, "interpro": [{"desc": "C-type lectin-like", "id": "IPR001304", "short_desc": "C-type_lectin-like"}, {"desc": "C-type lectin-like/link domain superfamily", "id": "IPR016186", "short_desc": "C-type_lectin-like/link_sf"}, {"desc": "C-type lectin fold", "id": "IPR016187", "short_desc": "CTDL_fold"}, {"desc": "Natural killer cell receptor-like, C-type lectin-like domain", "id": "IPR033992", "short_desc": "NKR-like_CTLD"}], "ipi": "IPI00032471", "map_location": "12p13.31", "name": "killer cell lectin like receptor B1", "other_names": ["C-type lectin domain family 5 member B", "killer cell lectin-like receptor subfamily B member 1", "killer cell lectin-like receptor subfamily B, member 1", "natural killer cell surface protein P1A"], "pantherdb": {"HGNC": "6373", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "107539", "ortholog_type": "O", "panther_family": "PTHR46784", "taxid": 10090, "uniprot_kb": "P27812"}, {"MGI": "107538", "ortholog_type": "O", "panther_family": "PTHR46784", "taxid": 10090, "uniprot_kb": "P27814"}, {"MGI": "107540", "ortholog_type": "LDO", "panther_family": "PTHR46784", "taxid": 10090, "uniprot_kb": "P27811"}, {"RGD": "2975", "ortholog_type": "O", "panther_family": "PTHR46784", "taxid": 10116, "uniprot_kb": "A4KWA1"}, {"RGD": "1586149", "ortholog_type": "LDO", "panther_family": "PTHR46784", "taxid": 10116, "uniprot_kb": "P27471"}, {"MGI": "2442965", "ortholog_type": "O", "panther_family": "PTHR46784", "taxid": 10090, "uniprot_kb": "Q8VD98"}, {"RGD": "1583336", "ortholog_type": "O", "panther_family": "PTHR46784", "taxid": 10116, "uniprot_kb": "Q63378"}, {"MGI": "96877", "ortholog_type": "O", "panther_family": "PTHR46784", "taxid": 10090, "uniprot_kb": "Q0ZUP1"}, {"RGD": "1587563", "ortholog_type": "O", "panther_family": "PTHR46784", "taxid": 10116, "uniprot_kb": "Q0ZUP0"}], "uniprot_kb": "Q12918"}, "pathway": {"kegg": {"id": "hsa05144", "name": "Malaria - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-198933", "name": "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"}]}, "pdb": ["5MGR", "5MGS", "5MGT"], "pfam": "PF00059", "pharmgkb": "PA30162", "pharos": {"target_id": 7695, "tdl": "Tbio"}, "pir": "I38700", "prosite": "PS50041", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF167923", "relationship": "is"}, {"id": "GNF178829", "relationship": "is"}, {"id": "GNF189735", "relationship": "is"}, {"id": "GNF200641", "relationship": "is"}], "GNF_hs-oncomine_IDT-siRNA": [{"id": "GNF281648", "relationship": "is"}, {"id": "GNF281689", "relationship": "is"}, {"id": "GNF281730", "relationship": "is"}, {"id": "GNF281771", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF276244", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF102175", "relationship": "is"}, {"id": "GNF141830", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000012.12", "NC_060936.1"], "protein": "NP_002249.1", "rna": "NM_002258.3", "translation": {"protein": "NP_002249.1", "rna": "NM_002258.3"}}, "reporter": {"HG-U133_Plus_2": "214470_at", "HG-U95Av2": "35449_at", "HTA-2_0": "TC12001202.hg.1", "HuEx-1_0": "3443804", "HuGene-1_1": "7961059", "HuGene-2_1": "16761176"}, "summary": "Natural killer (NK) cells are lymphocytes that mediate cytotoxicity and secrete cytokines after immune stimulation. Several genes of the C-type lectin superfamily, including the rodent NKRP1 family of glycoproteins, are expressed by NK cells and may be involved in the regulation of NK cell function. The KLRB1 protein contains an extracellular domain with several motifs characteristic of C-type lectins, a transmembrane domain, and a cytoplasmic domain. The KLRB1 protein is classified as a type II membrane protein because it has an external C terminus. [provided by RefSeq, Jul 2008].", "symbol": "KLRB1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1334310"}, "unigene": "Hs.169824", "uniprot": {"Swiss-Prot": "Q12918"}, "wikipedia": {"url_stub": "KLRB1"}}